Characterization of Bactericidal Immune Responses following Vaccination with Acellular Pertussis Vaccines in Adults
Open Access
- 1 December 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (12) , 7175-7179
- https://doi.org/10.1128/iai.68.12.7175-7179.2000
Abstract
Sera from six adults, collected before and after acellular pertussis vaccination, and from a placebo control were examined for the ability to elicit two bactericidal immune defenses, (i) antibody-dependent complement-mediated bacterial lysis and (ii) opsonization and phagocytosis by human neutrophils. The samples were chosen based on low preimmunization titers and strong postimmunization responses to various combinations of vaccine antigens. All but two prevaccination samples demonstrated activity indicative of complement-mediated lysis. Preimmunization activity could have been due to prior infection or childhood immunization. Immunization did not result in improved bactericidal activity for any of the individuals, and in two cases immunization caused a statistically significant decrease in complement-mediated lysis. Similarly, opsonization with the postimmunization sera failed to enhance attachment or phagocytosis of bacteria by neutrophils, and one postimmunization sample with a strong response to filamentous hemagglutinin caused an inhibition of phagocytosis that was statistically significant compared to that observed for the no-serum control. In summary, booster immunization of adults with acellular pertussis vaccines was not found to increase bactericidal activity over preimmunization levels. Identifying ways to promote bactericidal immune responses might improve the efficacy of acellular pertussis vaccines.Keywords
This publication has 24 references indexed in Scilit:
- Neutralizing Antibodies to Adenylate Cyclase Toxin Promote Phagocytosis ofBordetella pertussisby Human NeutrophilsInfection and Immunity, 2000
- Bordetella pertussisVirulence Factors Affect Phagocytosis by Human NeutrophilsInfection and Immunity, 2000
- Phagocytosed Bordetella pertussis Fails To Survive in Human NeutrophilsInfection and Immunity, 2000
- A Randomized Clinical Trial of Acellular Pertussis Vaccines in Healthy Adults: Dose‐Response Comparisons of 5 Vaccines and Implications for Booster ImmunizationThe Journal of Infectious Diseases, 1999
- Review of the Biology of Bordetella pertussisBiologicals, 1999
- Serum resistance inbvg-regulated mutants ofBordetella pertussisFEMS Microbiology Letters, 1998
- Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0Immunology, 1996
- Plasma exudation as a first line respiratory mucosal defenceClinical and Experimental Allergy, 1991
- PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTSThe Lancet, 1988
- Pertussis Toxin and Extracytoplasmic Adenylate Cyclase as Virulence Factors of Bordetella pertussisThe Journal of Infectious Diseases, 1984